Latest Breaking News On - Psoriasis treatment center - Page 1 : comparemela.com

Healio Dermatology announces new Peer Perspective Board

Healio Dermatology announces new Peer Perspective Board
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of southern californiaNew yorkNew jerseySan franciscoSan diegoEmma guttman yasskyGinettea okoyeMacrene alexiadesJamesj leydenJohne harrisBrett kingMarier davisKristen dowdJoelm gelfandAdam friedman

Psoriasis Treatment Center of New Jersey Reports Positive Results for Tapinarof in Psoriasis Trial

In this study, 52% of adult patients achieved the treat-to-target goal of 1% BSA or less within 3 months of incorporating tapinarof cream into their biologic regimen.

New jerseyUnited statesNational psoriasis foundationPsoriasis treatment centerSchweiger dermatology groupDermatology timesPsoriasis areaSeverity indexTapinarof cream for psoriasisTapinarof clinical trial

Topical halcinonide may benefit patients with psoriasis with inadequate biologics response

Topical halcinonide may benefit patients with psoriasis with inadequate biologics response
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesPsoriasis treatment centerCentral new jersey

Schweiger Dermatology Group Acquires Windsor Dermatology in East Windsor, New Jersey

/PRNewswire/ Schweiger Dermatology Group, the largest dermatology practice in the Northeast, has announced the acquisition of Windsor Dermatology in East.

New yorkUnited statesNew jerseyEast windsorAlexa hetzelWendy myersMatthew halpernDavid nievesBrianna butlerEric schweigerKristen teixeiraJessica simonFastest growing private companies in americaNational psoriasis foundationSchweiger dermatology groupPrnewswire schweiger dermatology group

Dupixent shows consistent, long-term efficacy in real-world studies

MIAMI BEACH, Florida — In two-real world studies, Dupixent treatment led to similar rapid and sustained improvements in patients with atopic dermatitis, according to a poster presentation at South Beach Symposium. Dupixent (dupilumab), a fully monoclonal antibody that blocks the shared receptor component for interleukin (IL)-4 and IL-13, is approved for the treatment of patients with

United statesSouth beachNew jerseyMiami beachSun pharmaKristen dowdArcutis biotherapeuticsEli lillyBygabrielle capaldoTaro pharmaceutical industriesRegeneron pharmaceuticalsBoehringer ingelheimPsoriasis treatment centerSouth beach symposiumMenlo therapeuticsCentral new jersey